{
    "nct_id": "NCT05556525",
    "official_title": "NCLE Guided Randomized Controlled Trial for Lung Cancer Diagnosis",
    "inclusion_criteria": "* >= 21 years of age\n* Suspected PPN\n* Nodule size in computed tomography (CT) between 8 mm and 30 mm (largest dimension)\n* Ability to understand and willingness to sign a written informed consent and Health Insurance Portability and Accountability Act (HIPAA) consent document\nHealthy volunteers allowed\nMust have minimum age of 21 Years",
    "exclusion_criteria": "* Inability or non-willingness to provide informed consent\n* Failure to comply with the study protocol\n* Patients with known allergy for fluorescein or risk factors for an allergic reaction\n* Use of beta-blocker within 24 hours before the start of the bronchoscopic procedure\n* Possibly pregnant, pregnant or breastfeeding women\n* Patients with hemodynamic instability\n* Patients with refractory hypoxemia\n* Patients with a therapeutic anticoagulant that cannot be held for an appropriate interval before the procedure\n* Patients who are unable to tolerate general anesthesia according to the anesthesiologist\n* Patient undergoing chemotherapy\n* INTRA-OPERATIVE EXCLUSION/STOPPING CRITERIA:\n* The lesions are unable to be localized/confirmed by bronchoscopy\n* The procedure will be terminated if the patient develops a significant procedural complication as determined by the treating physician\n* The procedure will be terminated if the patient develops hemodynamic instability as determined by the treating physician",
    "miscellaneous_criteria": ""
}